[go: up one dir, main page]

DK1590467T3 - Anvendelse af regulatoriske sekvenser til specifik, transient ekspression i neuronalt bestemte celler - Google Patents

Anvendelse af regulatoriske sekvenser til specifik, transient ekspression i neuronalt bestemte celler

Info

Publication number
DK1590467T3
DK1590467T3 DK04705802.9T DK04705802T DK1590467T3 DK 1590467 T3 DK1590467 T3 DK 1590467T3 DK 04705802 T DK04705802 T DK 04705802T DK 1590467 T3 DK1590467 T3 DK 1590467T3
Authority
DK
Denmark
Prior art keywords
neuronal
cells
regulatory sequences
methods
transient expression
Prior art date
Application number
DK04705802.9T
Other languages
English (en)
Inventor
Sebastien Couillard-Despres
Claudia Karl
Hans-Georg Kuhn
Ludwig Aigner
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1590467T3 publication Critical patent/DK1590467T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278Knock-in vertebrates, e.g. humanised vertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00Modified animals
    • A01K2207/15Humanized animals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • A01K2267/0306Animal model for genetic diseases
    • A01K2267/0318Animal model for neurodegenerative disease, e.g. non- Alzheimer's
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00Use of cells in diagnostics
    • C12N2503/02Drug screening
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/008Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/80Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85Vector systems having a special element relevant for transcription from vertebrates mammalian
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/20Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK04705802.9T 2003-01-28 2004-01-28 Anvendelse af regulatoriske sekvenser til specifik, transient ekspression i neuronalt bestemte celler DK1590467T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03002027 2003-01-28
PCT/EP2004/000760 WO2004067751A1 (en) 2003-01-28 2004-01-28 Use of regulatory sequences for specific, transient expression in neuronal determined cells

Publications (1)

Publication Number Publication Date
DK1590467T3 true DK1590467T3 (da) 2010-01-18

Family

ID=32798732

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04705802.9T DK1590467T3 (da) 2003-01-28 2004-01-28 Anvendelse af regulatoriske sekvenser til specifik, transient ekspression i neuronalt bestemte celler

Country Status (8)

Country Link
US (4) US20070107071A1 (da)
EP (1) EP1590467B1 (da)
AT (1) ATE446371T1 (da)
DE (1) DE602004023692D1 (da)
DK (1) DK1590467T3 (da)
ES (1) ES2334231T3 (da)
PT (1) PT1590467E (da)
WO (1) WO2004067751A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10339727A1 (de) * 2003-08-22 2005-03-17 Max-Delbrück-Centrum für Molekulare Medizin Verfahren zur Bestimmung der adulten Neurogenese
NZ548926A (en) 2004-02-09 2009-07-31 Regenion Gmbh Inhibitors of TGF-R signaling for treatment of CNS disorders
US20090055941A1 (en) 2005-03-22 2009-02-26 Agency For Science, Technology And Research Novel Neural Cell Specific Promoter And Baculovirus And Method For Gene Delivery
US20060277612A1 (en) * 2005-05-26 2006-12-07 Small Daniel L Methods and compositions for defining gene function
WO2010065096A1 (en) * 2008-12-03 2010-06-10 The Trustees Of Culumbia University In The City Of New York Assay for screening antidepressants
WO2011002988A1 (en) * 2009-07-01 2011-01-06 Transposagen Biopharmaceuticals, Inc. Genetically modified rat models for severe combined immunodeficiency (scid)
US20110135613A1 (en) 2009-12-03 2011-06-09 The J. David Gladstone Institutes Methods for treating apolipoprotein e4-associated disorders
EP2330418A1 (en) 2009-12-04 2011-06-08 SYGNIS Bioscience GmbH & Co KG Methods of quantitative determination of neurogenesis in vivo
US9074222B2 (en) * 2013-01-25 2015-07-07 The University Of British Columbia DCX mini-promoters
US11229789B2 (en) 2013-05-30 2022-01-25 Neurostim Oab, Inc. Neuro activator with controller
JP2016523125A (ja) 2013-05-30 2016-08-08 グラハム エイチ. クリーシー 局所神経性刺激
SG11201605833PA (en) * 2014-01-17 2016-08-30 Sumitomo Chemical Co Method for manufacturing ciliary margin stem cells
EP3209306B1 (en) * 2014-10-20 2024-04-24 Neuralstem, Inc. Stable neural stem cells comprising an exogenous polynucleotide coding for a growth factor and methods of use thereof
US11077301B2 (en) 2015-02-21 2021-08-03 NeurostimOAB, Inc. Topical nerve stimulator and sensor for bladder control
WO2018026517A1 (en) * 2016-08-04 2018-02-08 Exxonmobil Research And Engineering Company Increasing scales, capacities, and/or efficiencies in swing adsorption processes with hydrocarbon gas feeds
MA71412A (fr) 2017-04-03 2025-04-30 Encoded Therapeutics, Inc. Expression de transgène sélective d'un tissu
EP3706856A4 (en) 2017-11-07 2021-08-18 Neurostim Oab, Inc. NON-INVASIVE NERVOUS ACTIVATOR WITH ADAPTIVE CIRCUIT
CN111727259B (zh) 2017-12-01 2024-04-19 编码治疗公司 工程化的dna结合蛋白
KR20220025834A (ko) 2019-06-26 2022-03-03 뉴로스팀 테크놀로지스 엘엘씨 적응적 회로를 갖는 비침습적 신경 활성화기
WO2021126921A1 (en) 2019-12-16 2021-06-24 Neurostim Solutions, Llc Non-invasive nerve activator with boosted charge delivery
US20230133201A1 (en) * 2020-03-11 2023-05-04 Remotor Therapeutics, Inc. Methods and materials for disseminating a protein throughout the central nervous system

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2861892A (en) 1991-10-04 1993-05-03 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Astrocyte-specific transcription of human genes
US5661032A (en) 1994-03-18 1997-08-26 Mcgill University Tα1 α-tubulin promoter and expression vectors
US6245564B1 (en) 1997-01-23 2001-06-12 Cornell Research Foundation, Inc. Method for separating cells
EP0918091A1 (en) * 1997-11-21 1999-05-26 Institut National De La Sante Et De La Recherche Medicale (Inserm) A gene called XLIS and the XLIS gene product, called doublecortin and their applications
US8263402B1 (en) 1998-10-19 2012-09-11 Cornell Research Foundation, Inc. Method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells
WO2001053503A1 (en) 2000-01-18 2001-07-26 Cornell Research Foundation, Inc. Neural progenitor cells from hippocampal tissue and a method for isolating and purifying them

Also Published As

Publication number Publication date
ATE446371T1 (de) 2009-11-15
US20110016547A1 (en) 2011-01-20
EP1590467B1 (en) 2009-10-21
US20090170099A1 (en) 2009-07-02
EP1590467A1 (en) 2005-11-02
ES2334231T3 (es) 2010-03-08
US8815505B2 (en) 2014-08-26
US7947448B2 (en) 2011-05-24
US8841430B2 (en) 2014-09-23
WO2004067751A1 (en) 2004-08-12
PT1590467E (pt) 2010-01-05
DE602004023692D1 (de) 2009-12-03
US20110020790A1 (en) 2011-01-27
US20070107071A1 (en) 2007-05-10

Similar Documents

Publication Publication Date Title
DK1590467T3 (da) Anvendelse af regulatoriske sekvenser til specifik, transient ekspression i neuronalt bestemte celler
Cheng et al. Ecological genomics of Anopheles gambiae along a latitudinal cline: a population-resequencing approach
Mezhoud et al. Global quantitative analysis of protein expression and phosphorylation status in the liver of the medaka fish (Oryzias latipes) exposed to microcystin-LR: I. Balneation study
Whitehead et al. Common functional targets of adaptive micro‐and macro‐evolutionary divergence in killifish
Gaun et al. Automated 16-plex plasma proteomics with real-time search and ion mobility mass spectrometry enables large-scale profiling in naked mole-rats and mice
Ross et al. Voluntary exercise normalizes the proteomic landscape in muscle and brain and improves the phenotype of progeroid mice
BR0315666A (pt) Dna de a34 e a33 do tipo 3, proteìnas, seus anticorpos e métodos de tratamento usando os mesmos
Parsons et al. Roles for Bmp4 and CaM1 in shaping the jaw: evo-devo and beyond
BRPI0612273B8 (pt) anticorpo de ligação a il-1 beta ou fragmento de ligação a il-1 beta do mesmo, ácido nucleico, vetor, e, composição
ATE471373T1 (de) Expression von endogenen genen durch homologe rekombination eines vektorkonstruktes mit zellulärer dna
Beck et al. Advancing human disease research with fish evolutionary mutant models
Itoi et al. Changes of carp FoF1-ATPase in association with temperature acclimation
Liu et al. Genetic signatures of high-altitude adaptation and geographic distribution in Tibetan sheep
Mortzfeld et al. Eco-aging: stem cells and microbes are controlled by aging antagonist FoxO
Leman et al. 3D-organotypic cultures to unravel molecular and cellular abnormalities in atopic dermatitis and ichthyosis vulgaris
EP2422615A3 (en) Dominant negative mutant krp protein protection of active cyclin-cdk complex inhibition by wild-type krp
Venkataraman et al. Decoding senescence of aging single cells at the nexus of biomaterials, microfluidics, and spatial omics
BRPI0406680A (pt) Métodos para selecionar um animal para ter propriedades desejadas genotìpicas ou fenotìpicas em potencial, para modular a trascrição de mrna de um gene igf2 em uma célula ou organismo provido com referido gene e para identificar um composto, composto, composição farmacêutica, e, uso de um composto
Gou et al. The effect of histidine residue modification on tyrosinase activity and conformation: inhibition kinetics and computational prediction
Cole et al. Enzyme polymorphisms in the house sparrow, Passer domesticus
Horvath et al. Pan-primate DNA methylation clocks
Atrian Metallothioneins in diptera
Chandramouli et al. Comparative glycoproteome analysis: dynamics of protein glycosylation during metamorphic transition from pelagic to benthic life stages in three invertebrates
Biziaev et al. HemK-like methyltransferases in the regulation of cellular processes
Smeds Exploring the genomic basis of thermal adaptation in the willow leaf beetle Chrysomela aeneicollis